Newly Approved Intranasal Epinephrine
On August 9, 2024, the U.S. Food and Drug Administration approved a 2-mg epinephrine nasal spray (brand name “neffy”) for the emergency treatment of
Related Articles
When Blurry Vision Clouds the Bigger Picture | NEJM
A 14-year-old patient presented to the ED with a 12-month history of joint pains and a 2-month history of headaches and blurry vision.
Postnatal betamethasone treatment in extremely preterm infants and risk of neurodevelopmental impairment: a cohort study
Objective To evaluate if postnatal treatment with betamethasone in extremely preterm infants was associated with neurodevelopmental impairment (NDI) at 6.5 years of age. Design Prospective…
Projected Impact and Cost-Effectiveness of Novel Molecular Blood-Based or Stool-Based Screening Tests for Colorectal Cancer | Annals of Internal Medicine
Background: Cell-free DNA blood tests (cf-bDNA) and next-generation stool tests could change colorectal cancer (CRC) screening. Objective: To estimate the clinical and economic impacts of…
Because Ned Said: FDA Is Sued Over Removal of Blockbuster Weight Loss Drug From Shortages List
Some outsourcers and pharmacies have capitalized on the shortages, producing compounded versions.
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy | NEJM
Transthyretin amyloidosis with cardiomyopathy (ATTR-CM) is a progressive, fatal disease. Vutrisiran, a subcutaneously administered RNA interference therapeutic agent, inhibits the production of hep…
Estimating Heart Failure Risk in the U.S. Population with the PREVENT Calculator
Clinicians might be unaware that PREVENT, the new cardiac risk calculator from the American Heart Association, can calculate both atherosclerotic
Expanding Clinical Benefits for GLP-1–Receptor Agonists
Semaglutide, a glucagon-like peptide-1 (GLP-1)–receptor agonist, and tirzepatide, a GLP-1 agonist and glucose-dependent insulinotropic
Is Perioperative Use of GLP-1 Agonists Safe?
Use of glucagon-like peptide-1 (GLP-1)–receptor agonists prior to procedures that involve sedation or general anesthesia has become a controversial
Minnesota Partnership awards four collaborative research grants for 2024 – Mayo Clinic News Network
The Minnesota Partnership for Biotechnology and Medical Genomics (MNP) has announced its four research awardees for 2024.
Revista Médica AFP Podcast
Revista Médica AFP Podcast es una versión en español del popular y práctico Podcast de AFP.
